# Variation IGFBP7 Markers and TIMP2 Induced by Injection of Contrast Iodized Drug at the Intensive Care Patient

> **NCT02881710** · — · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 50 (actual)

## Conditions studied

- Emergency

## Interventions

- **OTHER:** contrast product used to assess biomarkers variations

## Key facts

- **NCT ID:** NCT02881710
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-09
- **Primary completion:** 2016-03-27
- **Final completion:** 2016-03-27
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02881710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02881710, "Variation IGFBP7 Markers and TIMP2 Induced by Injection of Contrast Iodized Drug at the Intensive Care Patient". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02881710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*